Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study

Alessio G. Morganti Radiotherapy Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy; Palliative Therapies Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Vincenzo Picardi Radiotherapy Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Edy Ippolito Radiotherapy Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Mariangela Massaccesi Radiotherapy Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Gabriella Macchia Radiotherapy Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, ItalyCorrespondence[email protected]

Francesco Deodato Radiotherapy Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Gian Carlo Mattiucci Department of Radiotherapy, Policlinico Universitario “A. Gemelli”, Catholic University, Rome, Italy

Luciana Caravatta Radiotherapy Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Liberato Di Lullo Department of Oncology, “F. Veneziale” General Hospital, Isernia, Italy

Gianfranco Giglio Department of Oncology, “A. Cardarelli” General Hospital Campobasso, Italy

Rosa Tambaro Palliative Therapies Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Samantha Mignogna Palliative Therapies Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Paola Caprino Surgery Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Marcello Ingrosso Endoscopy Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Luigi Sofo Surgery Unit, Department of Oncology, “John Paul II” Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Numa Cellini Department of Radiotherapy, Policlinico Universitario “A. Gemelli”, Catholic University, Rome, Italy

Vincenzo Valentini Department of Radiotherapy, Policlinico Universitario “A. Gemelli”, Catholic University, Rome, Italy

show all

Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study

Table I. Dose cohorts.

Table II. Patient and tumor characteristics.

Table III. Nonhematologic toxicity during chemoradiation.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study

Figures & data

Table I. Dose cohorts.

Table II. Patient and tumor characteristics.

Table III. Nonhematologic toxicity during chemoradiation.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date